B-D-Galactose

B-D-Galactose

SCHEMBL9820002

COC(=O)Oc1cc(=O)cc2oc3ccccc3nc1-2.OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC5A2 P31639 1/20 0.40
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA7 P43166 1/20 0.37
CA9 Q16790 1/20 0.37
CA13 Q8N1Q1 1/20 0.37
HSD17B10 Q99714 6/20 0.36
KDM4E B2RXH2 5/20 0.36
ALDH1A1 P00352 5/20 0.36
HPGD P15428 5/20 0.36
CASP1 P29466 4/20 0.36
CASP7 P55210 4/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
MAPT P10636 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
ADK P55263 2/20 0.35
LGALS3 P17931 1/20 0.35
GLA P06280 2/20 0.34
GAA P10253 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
B-D-Galactose SCHEMBL9819987 0.89 LGALS8 (0.38) SLC5A2CA12CA1CA7CA9
SCHEMBL9819970 0.86 MEN1 (0.42) HSD17B10KDM4EALDH1A1HPGDMEN1
B-D-Galactose SCHEMBL9820042 0.83 SLC5A2 (0.38) SLC5A2CA12CA1CA7CA9
B-D-Galactose SCHEMBL9819963 0.78 CA12 (0.36) SLC5A2CA12CA1CA7CA9
B-D-Galactose SCHEMBL9820085 0.78 CA12 (0.36) SLC5A2CA12CA1CA7CA9
B-D-Galactose SCHEMBL8515088 0.76 SLC5A2 (0.49) SLC5A2KDM4EALDH1A1MEN1KMT2A
D-Galactose SCHEMBL2370315 0.76 SLC5A2 (0.49) SLC5A2KDM4EALDH1A1MEN1KMT2A
B-D-Galactose SCHEMBL1712843 0.76 SLC5A2 (0.49) SLC5A2KDM4EALDH1A1MEN1KMT2A
Beta-D-Glucose SCHEMBL383291 0.76 SLC5A2 (0.49) SLC5A2KDM4EALDH1A1MEN1KMT2A
B-D-Galactose SCHEMBL307802 0.76 SLC5A2 (0.49) SLC5A2KDM4EALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0156347-B1 GLYCOSIDES OF RESOFURIN DERIVATIVES, METHOD FOR THEIR PREPARATION AND THEIR USE IN THE DETERMINATION OF THE ACTIVITY OF GLYCOSIDASES Roche Diagnostics GmbH (DE) 1991-09-04 EP disclosed